| SLRN Average Annual Return Chart Since 2023 | |||
Also see: • SLRN YTD return | |||
| Average Annual Return Benchmarks |
|
Compare SLRN average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| SLRN Share Performance |
| SLRN Average Annual Return Table Since 2023 | ||||||||||||||||||||||||||||||
SLRN average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About ACELYRIN Inc |
| ACELYRIN is engaged in the identification, acquisition, development and commercialization of medicines for autoimmune and inflammatory diseases. Co.'s clinical and preclinical stage product candidates consisting of: izokibep, which is a small protein therapeutic designed to inhibit anti-interleukin-17A; lonigutamab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor for the treatment of chronic urticaria; and SLRN-517, which is a fully human IgG1 monoclonal antibody targeting c-KIT for the treatment of chronic urticaria. The SLRN average annual return since 2023 is shown above.
The Average Annual Return on the SLRN average annual return since 2023 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether SLRN average annual return since 2023 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the SLRN average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| SLRN Current Stock Quote |
 Free SLRN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| ACELYRIN (SLRN) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
SLRX Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!